Figures
Abstract
Studies of linkage and association in various ethnic populations have revealed many predisposing genes of multiple neurotransmitter systems for alcohol use disorders (AUD). However, evidence often is contradictory regarding the contribution of most candidate genes to the susceptibility of AUD. We, therefore, performed a case-control study to investigate the possible associations of genes selected from multiple neurotransmitter systems with AUD in a homogeneous Tibetan community population in China. AUD cases (N = 281) with an alcohol use disorder identification test (AUDIT) score ≥10, as well as healthy controls (N = 277) with an AUDIT score ≤5, were recruited. All participants were genotyped for 366 single nucleotide polymorphisms (SNPs) of 34 genes selected from those involved in neurotransmitter systems. Association analyses were performed using PLINK version 1.07 software. Allelic analyses before adjustment for multiple tests showed that 15 polymorphisms within seven genes were associated with AUD (p<0.05). After adjustment for the number of SNPs genotyped within each gene, only the association of a single marker (rs10044881) in HTR4 remained statistically significant. Haplotype analysis for two SNPs in HTR4 (rs17777298 and rs10044881) showed that the haplotype AG was significantly associated with the protective effect for AUD. In conclusion, the present study discovered that the HTR4 gene may play a marked role in the pathogenesis of AUD. In addition, this Tibetan population sample marginally replicated previous evidence regarding the associations of six genes in AUD.
Citation: Xu Y, Guo W-j, Wang Q, Lanzi G, Luobu O, Ma X-h, et al. (2013) Polymorphisms of Genes in Neurotransmitter Systems Were Associated with Alcohol Use Disorders in a Tibetan Population. PLoS ONE 8(11): e80206. https://doi.org/10.1371/journal.pone.0080206
Editor: Xiang Yang Zhang, Baylor College of Medicine, United States of America
Received: July 18, 2013; Accepted: September 30, 2013; Published: November 27, 2013
Copyright: © 2013 Xu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Funded by a grant from the National Nature Science Foundation of China (grant No. 30870889) and a grant from the Department of Science and Technology, Sichuan, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Alcohol use disorders (AUD) — including alcohol dependence (AD) and alcohol abuse (AA) — are worldwide problems that induce complex clinical symptoms by damaging most organs in the human body, as well as the central and peripheral nervous systems [1], [2]. The risk of AUD is explained by interactions among multiple environmental and genetic factors in which the ethanol metabolic system and most neurotransmitter systems are involved [3], [4]. Although many study results support the effect of the genes encoding different alcohol and acetaldehyde dehydrogenase on risk of AUD [5], [6], studies on the role of neurotransmitter genes have documented inconsistent results. For instance, although the associations of TaqI-A1 polymorphism of dopamine receptor D2 (DRD2) gene polymorphisms with AUD have been repeatedly reported in many studies [7], [8], [9], they have not been reported in numerous others [10].
There are two subgroups of gamma-aminobutyric acid (GABA) receptors (the GABAA receptors and the GABAB receptors). They both belong to the GABAergic system, which is a chief inhibitory neurotransmitter in the central nervous system. For this system, genetic investigators have focused on GABAA receptors and have documented conflicting evidence of the contributing role of the GABAA receptors on chromosome 4p (GABRA2, GABRB1, and GABRG1) and 5q33-34 (GABRA1, GABRA6, GABRB2, and GABRG2) in the development of AUD [11], [12], [13]. The association of the susceptivity, severity, and treatment response of AUD with some polymorphisms of serotonin transporter (5-HTT) and serotonin (5-HT) receptor genes had also been reported by several initial studies, and as a result, similar research in different populations has increased in recent years, but results are not conclusive [8], [14], [15].
Although animal models and imaging studies have suggested that some 5-HT receptors (such as HTR1A, HTR1B, and HTR3) might also play roles in the pathogenesis of AUD [16], [17], [18], only a limited number of genetic association studies were performed, yielding mixed results [19], [20]. Similarly, genes from other neurotransmitter systems — such as the neuropeptide Y (NPY) gene of neuropeptide Y system [21]; the neuronal nicotinic acetylcholine receptor beta 2 (CHRNB2) gene of cholinergic system [22]; period circadian clock 1 (PER1); and period circadian clock 2 (PER2) of period family [23] — were also found to be associated with AUD in some studies but failed to be replicated in other research [24]. In Chinese ethnic groups, relatively few studies have focused on the role of neurotransmitter genes in the pathogenesis of alcohol use disorders. Most of them studied populations in Taiwan, including Chinese Han and aboriginal minority groups [25]–[31], and a few studies recruited participants from Mainland Chinese populations [32], [33], [34]. These studies also documented inconclusive evidence for several genes in neurotransmitter systems, including DRD2, 5-HTT, and HTR1B [25], [29], [30], [32].
Nonetheless, aforementioned association studies have suggested the implicated role of candidate genes from neurotransmitter systems, including dopaminergic, GABAergic, glutamatergic, opioid, cholinergic, and serotonergic systems. Some of these genes are located in or close to chromosomal regions (in chromosomes 1, 2, 4, 5, 7, 11, 13, and 17) indicated by linkage studies [35], [36], [37], [38]. The inconsistent results for AUD studies were considered caused by multiple AUD vulnerable genes with small and diverse effect sizes in different populations [39]. Recently, several genome-wide association studies (GWAS) on AUD identified a number of modestly associated genes [40], [41], [42]. For example, Kendler et al. [43] found that the calcium-activated potassium channel subunit alpha-1 (KCNMA1) gene was associated with alcohol dependence in European Americans. Nevertheless, the results of most of those studies proved inconclusive after the conservative statistical correction, which further confirmed that the effect size of each candidate gene is weak and may differ in different populations.
To overcome the limitations of small-number-marker studies and the expensive cost of GWAS, it is necessary to choose a compromised alternative strategy. The new strategy is to select candidate genes from multiple neurotransmitter systems in a focused array based on the neurobiology of addiction and previously documented evidence. In the present study, we thus performed a case-control study to detect the associations with AUD of 34 genes selected from multiple neurotransmitter systems by using a set of samples collected from a homogeneous Tibetan population in China [44].
Methods
Participants and Clinical Assessments
We performed an epidemiological survey in 3171 individuals selected by the stratified cluster-random sampling method from four suburban counties of Lhasa City in Tibet [44]. The Chinese interview version of the Alcohol Use Disorders Identification Test (AUDIT) [45] — the reliability and validity of which had been proven good for application in this population [44] — was used to assess alcohol use disorders of respondents in the survey. Using DSM-IV diagnostic criteria according to SCID-P assessment as the gold criteria, we identified that the best cut-off point of AUDIT for diagnosing AUD in this population is 10, with both sensitivity and specificity >0.85, although the cut-off point for alcohol use disorders should be 6 if all cases need to be included (sensitivity was 1.00, but specificity was only 0.59) [44]. All respondents with an AUDIT score ≥10 (n = 419) were defined as AUD cases and invited to participate in molecular genetic research. Among those invited to participate in the study, 383 respondents agreed to be involved and provided oral mucosa samples. Accordingly, 350 respondents matched by age, gender, and years of education, with AUDIT score ≤5, were appropriately recruited as healthy control subjects for the molecular genetic study [46], [47]. After excluding poor-quality DNA samples which were not suitable for clip analysis, the present study included 281 cases and 277 healthy controls. Statistically significant deviation with p<0.01 between case group and control group was shown in AUDIT score (mean±SD for case group: 17.84±6.12; control group: 0.96±1.54). There was no significant difference (p>0.05) between the two groups in terms of sex ratios (case group: 164 males and 117 females; control group: 163 males and 114 females), age (case group: 47.70±12.19 years; control group: 47.89±13.73 years), and years of education (case group: 2.42±2.64 years; control group: 2.11±2.74 years). None of the control subjects had a family history of AUD or a lifetime history of any other psychiatric disorders. This study was approved by the Ethics Committee of West China Hospital, Sichuan University. The written informed consent forms were obtained from all participants.
Selection and Genotyping of Candidate SNPs
The criteria of candidate genes selection in this study were based on molecular pathway or previously reported evidence from linkage, association, or high-throughput analyses that were indicated to be related to AUD [22], [43], [48], [49]. The 34 genes selected from several systems — including serotonin, dopamine, GABA, opioid, NMDA, and stress (HPA axis and neuropeptide Y) — were assessed in the study. Genomic regions containing 4 kb upstream and 4 kb downstream of each candidate gene were screened for tagger SNPs using the University of California Santa Cruz (UCSC) Genome Bioinformatics database (http://genome.ucsc.edu) and the Broad Institute tagger tool (www.broadinstitute.org/mpg/tagger/server.html). After the linkage disequilibrium (LD) patterns were calculated (r2≥0.8), selected tagger SNPs were assessed using the criterion of Illumina GoldenGate Custom Panels Design Score >0.6. The Illumina 384 GoldenGate Array Matrix (Illumina, Inc.) for 366 SNPs of 34 genes was designed and used in the present study (Table 1).
Oral mucosa samples were obtained from all participants, and genomic DNA was extracted according to standard procedures. DNA concentrations were quantified by NanoDrop 8000 spectrophotometer and normalized to 50 ng/µL for the chip. All samples (5 µL) were genotyped using the custom panel individually, according to the manufacturer's protocol, on an Illumina BeadStation 500 G GoldenGate genotyping platform at Sichuan University.
Data Analysis
Allelic and haplotype association analyses were performed using PLINK version 1.07 software (http://pngu.mgh.harvard.edu/~purcell/plink) for all genotyping data. Samples with genotyping rates and SNPs with minor allele frequency of ≤0.05 were excluded; Hardy-Weinberg equilibrium (HWE) was tested (p≥0.001).
For haplotype association analysis, the LD was calculated between the pair of markers. Because each gene included in this study was selected using candidate-gene strategy rather than through random selection, statistical adjustments for multiple tests were performed for the number of SNPs genotyped within each gene [50], [51].
Results
Sixty-six of the 558 participants were excluded for low genotyping (MIND>0.05). After frequency and genotyping pruning, 336 SNPs remained, and the total genotyping rate in the remaining participants was 0.9728. Before adjusting for multiple tests, statistically significant deviations with p<0.05 between the case group and control group were observed in 15 polymorphisms within seven genes (Table 2). Among them, five SNPs, including two (rs17777298 and rs10044881) with p<0.01, were in HTR4 gene, and one and two SNPs were in GABRA1 and GABRB2, respectively (all three genes were located in chromosome 5q31-34). The other seven polymorphisms were in KCNMA1, SLC6A4, COMT, and GABRG1, located in chromosomes 10, 17, 22, and 4, respectively.
After adjustment for the number of SNPs within each gene, a single significant deviation (rs10044881, adjusted p value = 2.122×10−2) in HTR4 remained, which was observed in allelic frequencies of any examined single marker.
We then nominated the two polymorphisms with p<0.01 in HTR4 (rs17777298 and rs10044881, D′ = 0.69) to perform a haplotype association analysis. The result showed that the haplotype AG carried by 20.6% of AUD cases, versus 29.6% of the controls, was associated with the protective effect for AUD. The association remained statistically significant even after correction for multiple tests (Table 3).
Discussion
In this case-control study, we investigated markers selected from 34 genes in neurotransmitter systems to evaluate the role of potential candidate genes in the pathogenesis of AUD in the Tibetan population. Some markers in HTR4 are detected to be associated with AUD, and it is especially noteworthy that the association remained statistically significant after adjustment for multiple tests — not only for the single locus, but also for the haplotype. This finding positively echoes the finding in a GWAS study in a Korean population, which suggested that four interesting genes — the cholinergic receptor/muscarinic 3 (CHRM3) gene; the phosphodiesterase 4D/cyclicAMP-specific (PDE4D) gene; the neuronal periodic acid Schiff (PAS) domain protein 3 (NPAS3) gene; and the HTR4 gene — might be associated with amount of alcohol consumption from additive-model analyses with pooled data [52].
The human HTR4 gene was mapped to chromosome 5q31–33 [53]. Its product is a glycosylated transmembrane protein that fulfills the role of modulating various neurotransmitters' release and enhancing synaptic transmission in the central nervous system. The gene thus had been proposed to be implicated in anxiety and cognitive function [54]. Several studies have shown that HTR4 polymorphisms could predispose to attention deficit hyperactivity disorder (ADHD) and bipolar disorder [55], [56], while AUD was strongly associated with both ADHD and bipolar disorder [57], [58], [59], [60]. Because the 5-HT4 receptor can modulate release of neurotransmitters (acetylcholine, dopamine, serotonin, and GABA) [61], [62], it is possible that the genetic polymorphism of HTR4 influences the interaction of neurotransmitters in the pathogenesis of AUD, which result in the association of AUD with polymorphisms of HTR4.
In our study, in addition to the uniquely associated SNP, seven among the 14 SNPs marginally associated with AUD were located in the chromosome region 5q31-34, including four within HTR4 and three within the GABAA receptor gene family (rs4263535 of GABRA1, rs17059393 and rs17059409 of GABRB2). Previous research has shown that four strong AUD candidate GABAA receptor genes(GABRA1, GABRA6, GABRB2, and GABRG2)clustered together on locus 5q33-34 and are associated with AUD and its related traits [11], [12], [13]. It is thus possible that the association of markers in the HTR4 gene with AUD may reflect an indication on the chromosome region surrounding HTR4, rather than by HTR4 itself, due to linkage disequilibrium among markers on HTR4 and its surrounding region.
Nevertheless, there is evidence against this possibility. For example, the distance from HTR4 to either GABRA1 or GABRB2 was more than 10 Mb. Furthermore, our pair-wise LD analyses for rs10044881 (the unique associated SNP of HTR4) with rs4263535 (the marginally associated SNP of GABRA1), rs17059393, and rs17059409 (the two marginally associated SNPs of GABRB2), respectively, showed very weak LD (D′≤0.12) between them.
Apart from the novel finding of the association between AUD and HTR4, this study using a Tibetan sample also marginally replicated previous evidence regarding the associations of six genes (GABRA1, GABRB2, KCNMA1, SLC6A4, COMT, and GABRG1) with AUD. In previous studies, all six of the genes were found to be associated with AUD and related traits, although revealed effect sizes all were small. For example, the GABAA receptor subunit genes on 5q33-34 have been found to be involved in psychological and behavioral disorders [63]. They demonstrated important roles in the acute and chronic effects of alcohol on the central nervous system [64]. In addition, various evidence has indicated that these four GABAA receptor genes may contribute to the pathogenesis of AUD in several populations, including that of East Asia [65], [66], [67]. For example, Park et al. [12] reported that polymorphisms of the GABRA1 and GABRA6 receptor gene were associated with the development of alcoholism, and the polymorphisms of GABRA1 receptor were associated with the onset of alcoholism and alcohol withdrawal symptoms in the Korean population. However, several studies using the data from the Collaborative Study on the Genetics of Alcoholism (COGA) showed a weak relationship between the chromosome 5 cluster of GABAA receptor genes and AUD [13], [68]. Nevertheless, more evidence has been presented on the association of chromosome 4 cluster of GABAA receptor genes with AUD and related traits from investigators [69]. Kendler et al. [43] performed a GWAS for the symptoms of alcohol dependence in the European American and African American participants and discovered the most significant intragenic SNP of KCNMA1 in the European American sample. Although results were inconsistent, many studies still suggested that the serotonin transporter gene (5-HTT) is an important candidate gene for AUD and related traits [70], [14]. Extensive studies on a functional polymorphism (Val158Met) in the human catechol-O-methyltransferase (COMT) gene showed that the polymorphism (Val158Met) was one of the significant markers of genetic predisposition to AUD [71], [72]. COGA studies had linked alcohol dependence with the GABAA receptor gene family region that contains GABRG1 in the chromosome 4p [73], [74]. Enoch et al. [11] found GABRG1 SNPs and haplotypes were significantly associated with AUD in both Plains Indians and Finnish Caucasians. In the present study, the marginal results of these genes suggest they may also play roles in the pathogenesis of AUD in the Tibetan population. Nevertheless, the statistical significance of the association between these genes and AUD was weakened after controlling for multiple tests. This may be due to the major limitation of the present study — i.e., the sample size is not large enough to detect those genes' small effect sizes after a conservative statistical correction. Therefore, our results need to be replicated in the larger and independent samples.
In conclusion, the present study discovered that the HTR4 gene may play a marked role in the pathogenesis of AUD. In addition, it marginally replicated previous evidence regarding the associations of six genes (GABRA1, GABRB2, KCNMA1, SLC6A4, COMT, and GABRG1) with AUD in the Tibetan population. These findings enrich the knowledge regarding the genetic etiology of AUD.
Acknowledgments
We thank Jin Mei, Luo Dan, Sang Mu, Wang Mu, and Luosang Jiancai from Tibet University Medical College for their assistance with data collection.
Author Contributions
Conceived and designed the experiments: YX WJG TL XH XHL. Performed the experiments: YX YCW. Analyzed the data: YX QW XL. Contributed reagents/materials/analysis tools: XHM WD QW. Wrote the paper: YX WJG TL XH. Collected the samples and information: WJG GL OL PZ BZ.
References
- 1. Baumberg B, Anderson P (2008) Trade and health: how World Trade Organization (WTO) law affects alcohol and public health. Addiction 103: 1952–1958.
- 2. Testino G (2008) Alcoholic diseases in hepato-gastroenterology: a point of view. Hepatogastroenterolog 55: 371–377.
- 3. Schuckit MA, Smith TL (2006) An evaluation of the level of response to alcohol, externalizing symptoms, and depressive symptoms as predictors of alcoholism. J Stud Alcohol 67: 215–227.
- 4. Timberlake DS, Hopfer CJ, Rhee SH, Friedman NP, Haberstick BC, et al. (2007) College attendance and its effect on drinking behaviors in a longitudinal study of adolescents. Alcohol Clin Exp Res 31: 1020–1030.
- 5. Higuchi S, Matsushita S, Kashima H (2006) New findings on the genetic influences on alcohol use and dependence. Curr Opin Psychiatry 19: 253–265.
- 6. Zintzaras E, Stefanidis I, Santos M, Vidal F (2006) Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease? Hepatology 43: 352–361.
- 7. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, et al. (1990) Allelic association of humandopamine D2 receptor gene in alcoholism. J Am Med Assoc 263: 2055–2060.
- 8. Foley PF, Loh EW, Innes DJ, Williams SM, Tannenberg AE, et al. (2004) Association studies of neurotransmitter gene polymorphisms in alcoholic Caucasians. Ann N Y Acad Sci 1025: 39–46.
- 9. Noble EP, Zhang X, Ritchie TL, Sparkes RS (2000) Haplotypes at the DRD2 locus and severe alcoholism. Am J Med Genet 96: 622–631.
- 10. Heinz A, Sander T, Harms H, Finckh U, Kuhn S, et al.( 1996) Lack of allelic association of dopamine D1 and D2(TaqIA) receptor gene polymorphisms with reduced dopaminergic sensitivity to alcoholism. Alcohol Clin ExpRes 20: 1109–1113.
- 11. Enoch MA, Hodgkinson CA, Yuan Q, Albaugh B, Virkkunen M, et al. (2009) GABRG1 and GABRA2 as independent predictors for alcoholism in two populations. Neuropsychopharmacology 34: 1245–1254.
- 12. Park CS, Park SY, Lee CS, Sohn JW, Hahn GH, et al. (2006) Association between alcoholism and the genetic polymorphisms of the GABAA receptor genes on chromosome 5q33-34 in Korean population. J Korean Med Sci 21: 533–538.
- 13. Dick DM, Edenberg HJ, Xuei X, Goate A, Hesselbrock V, et al. (2005) No association of the GABAA receptor genes on chromosome 5 with alcoholism in the collaborative study on the genetics of alcoholism sample. Am J Med Genet B Neuropsychiatr Genet 132B: 24–28.
- 14. Feinn R, Nellissery M, Kranzler HR (2005) Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence. Am J Med Genet B Neuropsychiatr Genet 133: 79–84.
- 15. Dick DM, Plunkett J, Hamlin D, Nurnberger J Jr, Kuperman S, et al. (2007) Association analyses of the serotonin transporter gene with lifetime depression and alcohol dependence in the Collaborative Study on the Genetics of Alcoholism (COGA) sample. Psychiatr Genet 17: 35–38.
- 16. Martinez D, Slifstein M, Gil R, Hwang DR, Huang Y, et al. (2009) Positron emission tomography imaging of the serotonin transporterand 5-HT(1A) receptor in alcohol dependence. Biol Psychiatry 65: 175–180.
- 17. Hu J, Henry S, Gallezot JD, Ropchan J, Neumaier JF, et al. (2010) Serotonin 1B Receptor Imaging in Alcohol Dependence. BIOL PSYCHIATRY 67: 800–803.
- 18. Yoshimoto K, Yayama K, Sorimachi Y, Tani J, Ogata M, et al. (1996) Possibility of 5-HT3 receptor involvement in alcohol dependence: a microdialysis study of nucleus accumbens dopamine and serotonin release in rats with chronic alcohol consumption. Alcohol Clin Exp Res 20: 311A–319A.
- 19. Polina ER, Contini V, Hutz MH, Bau CH (2009) The serotonin 2A receptor gene in alcohol dependence and tobacco smoking. Drug Alcohol Depend 101: 128–131.
- 20. Gorwood P, Lanfumey L, Hamon M (2004) Alcohol dependence and polymorphisms of serotonin-related genes. Med Sci (Paris) 20: 1132–1138.
- 21. Lappalainen J, Kranzler HR, Malison R, Price LH, Van Dyck C, et al. (2002) A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. Arch Gen Psychiatry 59: 825–831.
- 22. Ehringer MA, Clegg HV, Collins AC, Corley RP, Crowley T, et al. (2007) Association of the neuronal nicotinic receptor beta2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine. Am J Med Genet B Neuropsychiatr Genet 144B: 596–604.
- 23. Dong L, Bilbao A, Laucht M, Henriksson R, Yakovleva T, et al. (2011) Effects of the circadian rhythm gene period 1 (per1) on psychosocial stress-inducedalcohol drinking. Am J Psychiatry 168: 1090–1098.
- 24. Koehnke MD, Schick S, Lutz U, Willecke M, Koehnke AM, et al. (2002) Severity of Alcohol Withdrawal Symptoms and the T1128C Polymorphism of the Neuropeptide Y Gene. J Neural Transm 109: 1423–1429.
- 25. Lee JF, Lu RB, Ko HC, Chang FM, Yin SJ, Pakstis AJ, et al. (1999) No association between DRD2 locus and alcoholism after controlling the ADH and ALDH genotypes in Chinese Han population. Alcohol Clin Exp Res 23: 592–599.
- 26. Chen WJ, Chen CH, Huang J, Hsu YP, Seow SV, Chen CC, et al. (2001) Genetic polymorphisms of the promoter region of dopamine D2 receptor and dopamine transporter genes and alcoholism among four aboriginal groups and HanChinese in Taiwan. Psychiatr Genet 11: 187–195.
- 27.
Loh el-W, Fann CS, Chang YT, Chang CJ, Cheng AT (2004) Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han. Alcohol Clin Exp Res:15–19.
- 28. Loh el-W, Lane HY, Chen CH, Chang PS, Ku LW, et al. (2006) Glutamate decarboxylase genes and alcoholism in Han Taiwanese men. Alcohol Clin Exp Res 30: 1817–1823.
- 29. Huang SY, Lin WW, Wan FJ, Chang AJ, Ko HC, et al. (2007) Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence. J Psychiatry Neurosci 32: 185–192.
- 30. Lee SY, Lin WW, Huang SY, Kuo PH, Wang CL, et al. (2009) The relationship between serotonin receptor 1B polymorphisms A-161T and alcohol dependence. Alcohol Clin Exp Res 33: 1589–1595.
- 31. Lee SY, Hahn CY, Lee JF, Huang SY, Chen SL, et al. (2010) MAOA interacts with the ALDH2 gene in anxiety-depression alcohol dependence. Alcohol Clin Exp Res 34: 1212–1218.
- 32. Cao JX, Hu J, Ye XM, Xia Y, Haile CA, Kosten TR, et al. (2011) Association between the 5-HTR1B gene polymorphisms and alcohol dependence in a Han Chinese population. Brain Res 1376: 1–9.
- 33. Wang XJ, Zhong SR, Bao JJ, Dou SJ, Wu WY, et al. (2011) Association of polymorphism in the serotonin transporter gene promote with the susceptibility to alcohol dependence in Yunnan Han Population. Yi Chuan 33: 48–53.
- 34. Huang C, Jin AH, Li CH, Han HM, Piao XX (2012) The relation between OPRMl gene A118G polymorphism and alcoholic liver disease,alcohol-dependent in Korean-Chinese and Han nationality men of Yanbian area. Journal of Medical Science Yanbian University 35: 199–205.
- 35. Agrawal A, Hinrichs AL, Dunn G, Bertelsen S, Dick DM, et al. (2008) Linkage scan for quantitative traits identifies new regions of interest for substance dependence in the Collaborative Study on the Genetics of Alcoholism (COGA) sample. Drug Alcohol Depend 93: 12–20.
- 36. Gelernter J, Kranzler HR, Panhuysen C, Weiss RD, Brady K, et al. (2009) Dense genomewide linkage scan for alcohol dependence in African Americans: significant linkage on chromosome 10. Biol Psychiatry 65: 111–115.
- 37. Hill SY, Shen S, Zezza N, Hoffman EK, Perlin M, et al. (2004) A genome wide search for alcoholism susceptibility genes. Am J Med Genet B Neuropsychiatr Genet 128B: 102–113.
- 38. Kuo PH, Neale MC, Riley BP, Webb BT, Sullivan PF, et al. (2006) Identification of susceptibility loci for alcohol-related traits in the Irish Affected Sib Pair Study of Alcohol Dependence. Alcohol Clin Exp Res 30: 1807–1816.
- 39. Nurnberger JI Jr, Bierut LJ (2007) Seeking the connections: alcoholism and our genes. Sci Am. 296: 46–53.
- 40. Bierut LJ, Agrawal A, Bucholz KK, Doheny KF, Pugh E, et al. (2010) A genome-wide association study of alcohol dependence. Proc Natl Acad Sci U S A 107: 5082–5087.
- 41. Edenberg HJ, Koller DL, Xuei X, Wetherill L, McClintick JN, et al. (2010) Genome-wide association study of alcohol dependence implicates a region on chromosome 11. Alcohol Clin Exp Res 34: 840–852.
- 42. Treutlein J, Cichon S, Ridinger M, Wodarz N, Soyka M, et al. (2009) Genome-wide association study of alcohol dependence. Arch Gen Psychiatry 66: 773–784.
- 43. Kendler KS, Kalsi G, Holmans PA, Sanders AR, Aggen SH, et al. (2011) Genomewide association analysis of symptoms of alcohol dependence in the molecular genetics of schizophrenia (MGS2) control sample. Alcohol Clin Exp Res. 35: 963–975.
- 44. Guo W, Lanzi G, Luobu O, Ma X, Zhen P, et al. (2008) An epidemiological survey of alcohol use disorders in a Tibetan population. Psychiatry Res 159: 56–66.
- 45.
Babor TF, John C, Saunders JB, Maristela G (2001) AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Health Care. 2nd edition. Geneva, Switzerland: World Health Organization/MSD/MSB.
- 46. Guo W, Wang Q, Lanzi G, Luobu O, Ma X, Wang Y, et al. (2010) Interaction among genes influencing ethanol metabolism and sex is association with alcohol use disorders in a Tibet population. Am J Med Genet B Neuropsychiatr Genet 153B: 561–9.
- 47. Guo WJ, Wang Q, Lanzi G, Luobu O, Ma XH, Wang YC, et al. (2011) Gender-specific interactions between alcohol metabolism genes and severity of quantitative alcohol-related-traitsin a Tibetan population. Neurosci Lett 495: 22–5.
- 48. Köhnke MD (2008) Approach to the genetics of alcoholism: a review based on pathophysiology. Biochem Pharmacol 75: 160–177.
- 49. Kimura M, Higuchi S (2011) Genetics of alcohol dependence. Psychiatry Clin Neurosci 65: 213–225.
- 50. Lan Q, Morton LM, Armstrong B, Hartge P, Menashe I, et al. (2009) Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies. Blood 114: 264–267.
- 51. Perlis RH, Fijal B, Dharia S, Houston JP (2013) Pharmacogenetic investigation of response to duloxetine treatment in generalized anxiety disorder. Pharmacogenomics J 13: 280–285.
- 52. Baik I, Cho NH, Kim SH, Han BG, Shin C (2011) Genome-wide association studies identify genetic loci related to alcohol consumption in Korean men. Am J Clin Nutr 93: 809–16.
- 53. Claeysen S, Faye P, Sebben M, Lemaire S, Bockaert J, et al. (1997) Cloning and expression of human 5-HT4S receptors. Effect of receptor density on their coupling to adenylyl cyclase. NeuroReport 8: 3189–3196.
- 54. King MV, Marsden CA, Fone KCF (2008) A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory. Trends Pharmacol Sci 29: 482–492.
- 55. Li J, Wang Y, Zhou R, Wang B, Zhang H, et al. (2006) Association of attention-deficit/hyperactivity disorder with serotonin 4 receptor gene polymorphisms in Han Chinese subjects. Neurosci. Lett 401: 6–9.
- 56. Ohtsuki T, Ishiguro H, Detera-Wadleigh SD, Toyota T, Shimizu H, et al. (2002) Association between serotonin 4 receptor gene polymorphisms and bipolar disorder in Japanese case-control samples and the NIMH Genetics Initiative Bipolar Pedigrees. Mol Psychiatry 7: 954–961.
- 57. August GJ, Winters KC, Realmuto GM, Fahnhorst T, Botzet A, et al. (2006) Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants. J Am Acad Child Adolesc Psychiatry 45: 824–832.
- 58. Molina BS, Pelham WE, Gnagy EM, Thompson AL, Marshal MP (2007) Attention-deficit/hyperactivity disorder risk for heavy drinking and alcohol use disorder is age specific. Alcohol Clin Exp Res 31: 643–654.
- 59. Jacob T, Waterman B, Heath A, True W, Bucholz KK, et al. (2003) Genetic and environmental effects on offspring alcoholism: new insights using an offspring-of-twins design. Archives of General Psychiatry 60: 1265–1272.
- 60. Hayden EP, Nurnberger JI Jr (2006) Molecular genetics of bipolar disorder. Genes, Brain, and Behavior 5: 85–95.
- 61. Bianchi C, Rodi D, Marino S, Beani L, Siniscalchi A (2002) Dual effects of 5-HT4 receptor activation on GABA release from guinea pig hippocampal slices. Neuroreport 13: 2177–2180.
- 62. Fink KB, Gothert M (2007) 5-HT receptor regulation of neurotransmitter release. Pharmacol. Rev 59: 360–417.
- 63. Kerner B, Brugman DL, Freimer NB (2007) Evidence of linkage to psychosis on chromosome 5q33-34 in pedigrees ascertained for bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 144B: 74–78.
- 64. Grobin AC, Matthews DB, Devaud LL, Morrow AL (1998) The role of GABAA receptors in the acute and chronic effects of ethanol. Psychopharmacology 139: 2–19.
- 65. Loh EW, Smith I, Murray R, McLaughlin M, McNulty S, et al. (1999) Association between variants at the GABAAbeta2, GABAAalpha6 and GABAAgamma2 gene cluster and alcohol dependence in a Scottish population. Mol Psychiatry 4: 539–544.
- 66. Loh EW, Higuchi S, Matsushita S, Murray R, Chen CK, et al. (2000) Association analysis of the GABA(A) receptor subunit genes cluster on 5q33-34 and alcohol dependence in a Japanese population. Mol Psychiatry 5: 301–307.
- 67. Radel M, Vallejo RL, Iwata N, Aragon R, Long JC, et al. (2005) Haplotype-based localization of an alcohol dependence gene to the 5q34 {gamma}-aminobutyric acid type A gene cluster. Arch Gen Psychiatry 62: 47–55.
- 68. Song J, Koller DL, Foroud T, Carr K, Zhao J, et al. (2003) Association of GABA(A) receptors and alcohol dependence and the effects of genetic imprinting. Am J Med Genet B Neuropsychiatr Genet 117B: 39–45.
- 69. Agrawal A, Edenberg HJ, Foroud T, Bierut LJ, Dunne G, et al. (2006) Association of GABRA2 with drug dependence in the collaborative study of the genetics of alcoholism sample. Behav Genet 36: 640–650.
- 70. Konishi T, Calvillo M, Leng A, Lin K, Wan Y (2004) Polymorphisms of the dopamine D2 receptor, serotonin transporter, and GABAA receptor b3 subunit genes and alcoholism in Mexican-Americans. Alcohol 32: 45–52.
- 71. Kibitov AO, Voskoboeva EIu, Brodianskiı ˘ VM, Chuprova NA, Smirnova EV (2010) Association study of the Val158Met polymorphism of the catechol-O- methyltransferase gene and alcoholism and heroin dependence: the role of a family history. Zh Nevrol Psikhiatr Im S S Korsakova 110: 84–88.
- 72. Köhnke MD, Wiatr G, Kolb W, Köhnke AM, Schick S, et al. (2003) Plasma homovanillic acid: a significant association with alcoholism is independent of a functional polymorphism of the human catechol-O-methyltransferase gene. Neuropsychopharmacology 28: 1004–1010.
- 73. Reich T, Edenberg HJ, Goate A, Williams JT, Rice JP, et al. (1998) Genome-wide search for genes affecting the risk for alcohol dependence. Am J Med Genet 81: 207–215.
- 74. Long JC, Knowler WC, Hanson RL, Robin RW, Urbanek M, et al. (1998) Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am J Med Genet 81: 216–221.